Sexually Transmitted Diseases

>

Latest News

Gepotidacin's Phase 3 Trial for Gonorrhea Treatment Shows Efficacy
Gepotidacin's Phase 3 Trial for Gonorrhea Treatment Shows Efficacy

February 28th 2024

Promising oral antibiotic candidate for the treatment of uncomplicated urogenital gonorrhea

Doxy-PEP to Prevent Bacterial STIs: Proceed But With Caution
Doxy-PEP to Prevent Bacterial STIs: Proceed But With Caution

February 20th 2024

Increase in Incidence Rates of STIs in Adolescents During the COVID-19 Pandemic
Increase in Incidence Rates of STIs in Adolescents During the COVID-19 Pandemic

February 18th 2024

CDC Report: Syphilis Incidence Rate Continues to Increase and Shows Rising Trend Over Several Years
CDC Report: Syphilis Incidence Rate Continues to Increase and Shows Rising Trend Over Several Years

January 30th 2024

A Growing Concern About Gonorrhea's Resistance to Antibiotics
A Growing Concern About Gonorrhea's Resistance to Antibiotics

January 26th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.